» Articles » PMID: 30165605

Long-term Stability of Resistance to Latent Mycobacterium Tuberculosis Infection in Highly Exposed Tuberculosis Household Contacts in Kampala, Uganda

Overview
Journal Clin Infect Dis
Date 2018 Aug 31
PMID 30165605
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Resistance to latent Mycobacterium tuberculosis (M.tb) infection, identified by persistently negative tuberculin skin tests (TST) and interferon-gamma release assays (IGRA), after close contact with pulmonary tuberculosis (TB) patients has not been extensively characterized. Stability of this "resistance" beyond 2 years from exposure is unknown.

Methods: 407 of 657 eligible human immunodeficiency virus (HIV)-negative adults from a TB household contact study with persistently negative TST (PTST-) or with stable latent M.tb infection (LTBI) were retraced 9.5 years (standard deviation = 3.2) later. Asymptomatic retraced contacts underwent 3 IGRAs and follow-up TST, and their M.tb infection status classified as definite/possible/probable.

Results: Among PTST- with a definite classification, 82.7% were concordantly TST-/ quantiferon-TB Gold- (QFT-), and 16.3% converted to TST+/QFT+ LTBI. Among original LTBI contacts, 83.6% remained LTBI, and 3.9% reverted their TST and were QFT-. Although TST and QFT concordance was high (κ = 0.78), 1.0% of PTST and 12.5% of original LTBI contacts could not be classified due to discordant TST and QFT results. Epidemiological variables did not differ between retraced PTST- and LTBI contacts.

Conclusion: Resistance to LTBI, defined by repeatedly negative TST and IGRA, in adults who have had close contact with pulmonary TB patients living in TB-endemic areas, is a stable outcome of M.tb exposure. Repeated longitudinal measurements with 2 different immune assays and extended follow-up provide enhanced discriminatory power to identify this resister phenotype and avoid misclassification. Resisters may use immune mechanisms to control aerosolized M.tb that differ from those used by persons who develop "classic" LTBI.

Citing Articles

Association of Mycobacterium tuberculosis aerosolization and HIV coinfection in the index case with T cell responses in household contacts.

Njagi L, Nduba V, Murithi W, Mwongera Z, Cook K, Mecha J Sci Rep. 2025; 15(1):224.

PMID: 39748008 PMC: 11695726. DOI: 10.1038/s41598-024-83965-5.


Household contact antigen-specic TNF and IL-2 T-cell responses and impact of index case Mycobacterium tuberculosis aerosolization and HIV Co-infection.

Njagi L, Nduba V, Murithi W, Mwongera Z, Cook K, Mecha J Res Sq. 2024; .

PMID: 39606489 PMC: 11601854. DOI: 10.21203/rs.3.rs-4815117/v1.


Epigenetic programming of host lipid metabolism associated with resistance to TST/IGRA conversion after exposure to .

Dill-McFarland K, Simmons J, Peterson G, Nguyen F, Campo M, Benchek P mSystems. 2024; 9(9):e0062824.

PMID: 39162406 PMC: 11406990. DOI: 10.1128/msystems.00628-24.


Recasting resistance to Mycobacterium tuberculosis.

Andrews J Nat Immunol. 2024; 25(8):1316-1318.

PMID: 39048789 DOI: 10.1038/s41590-024-01907-9.


Specific CD4 T cell phenotypes associate with bacterial control in people who 'resist' infection with Mycobacterium tuberculosis.

Sun M, Phan J, Kieswetter N, Huang H, Yu K, Smith M Nat Immunol. 2024; 25(8):1411-1421.

PMID: 38997431 PMC: 11291275. DOI: 10.1038/s41590-024-01897-8.


References
1.
Tameris M, Hatherill M, Landry B, Scriba T, Snowden M, Lockhart S . Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet. 2013; 381(9871):1021-8. PMC: 5424647. DOI: 10.1016/S0140-6736(13)60177-4. View

2.
Simmons J, Stein C, Seshadri C, Campo M, Alter G, Fortune S . Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection. Nat Rev Immunol. 2018; 18(9):575-589. PMC: 6278832. DOI: 10.1038/s41577-018-0025-3. View

3.
Houben R, Dodd P . The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling. PLoS Med. 2016; 13(10):e1002152. PMC: 5079585. DOI: 10.1371/journal.pmed.1002152. View

4.
Acuna-Villaorduna C, Jones-Lopez E, Fregona G, Marques-Rodrigues P, Gaeddert M, Geadas C . Intensity of exposure to pulmonary tuberculosis determines risk of tuberculosis infection and disease. Eur Respir J. 2018; 51(1). PMC: 6719538. DOI: 10.1183/13993003.01578-2017. View

5.
Stein C, Hall N, Malone L, Mupere E . The household contact study design for genetic epidemiological studies of infectious diseases. Front Genet. 2013; 4:61. PMC: 3639375. DOI: 10.3389/fgene.2013.00061. View